Heart Disease News and Research

Latest Heart Disease News and Research

Statins may improve longevity of hip replacement surgery

The use of statins - drugs commonly prescribed to help lower cholesterol levels - may play an important role in decreasing complications among patients undergoing total hip replacement (THR), according to a study published in the May 2010 issue of the Journal of Bone and Joint Surgery (JBJS).

4 May 2010

NIH awards Hutchinson Center $10.24M for research of breast cancer disparities in Hispanic women

The National Institutes of Health has awarded $10.24 million to Fred Hutchinson Cancer Research Center to lead a five-year study that aims to understand and prevent breast cancer disparities in Hispanic women.

4 May 2010

Difference between grief and depression

"A son is a son till he takes a wife, a daughter is a daughter all her life," goes the old Irish saying. Though there is an extraordinary bond between every mother and child there is something unique about the relationship between a mother and daughter

4 May 2010

Depressive symptoms after ACS associated with vascular brain changes

A new study published in the current issue of Psychotherapy and Psychosmatics has examined brain activity after a heart attack.This study provides the first evidence that persistent depressive symptoms after acute coronary syndrome are associated with vascular brain changes.

4 May 2010

Sepracor issued FDA Complete Response Letter for STEDESA NDA

Sepracor Inc., a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP), today announced that the U.S. Food and Drug Administration (FDA, or Agency) has issued a Complete Response Letter to Sepracor's New Drug Application (NDA) for its antiepileptic drug candidate, STEDESA™, which is the company's proposed trade name for eslicarbazepine acetate.

4 May 2010

Sorin Group to distribute CardioMedical's entire Cardio Vision MIS Portfolio

Sorin Group, a global company and a leader in the treatment of cardiovascular diseases, announced today that it has entered into a distribution agreement, effective May 1, 2010, with CardioMedical GmbH, making Sorin Group, CardioMedical's selected partner for the entire Cardio Vision™ MIS Portfolio which is a comprehensive catalogue of minimally invasive cardiac surgery instruments and accessories.

3 May 2010

Weight loss through caloric restriction and increase in physical activity improve symptoms of GERD

Gastroesophageal reflux disease (GERD) is a debilitating problem for sufferers -- heartburn, difficulty swallowing, chest pain and acid reflux. According to a Mayo Clinic study that will be presented at Digestive Disease Week (DDW) 2010 in New Orleans May 1-5, even moderate weight gain can exacerbate those symptoms, DDW is the largest international gathering of physicians and researcher in the field of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

3 May 2010

FDA issues advisory on prostate cancer drugs

Gonadotropin-Releasing Hormone (GnRH) agonists, a class of medications primarily used to treat men with prostate cancer, have been associated with a small increased risk for diabetes, heart attack, stroke, and sudden death in men treated with one of the medications, according to a preliminary and ongoing analysis of several studies by the U.S. Food and Drug Administration.

3 May 2010

BioTime acquires ES Cell International

BioTime, Inc., a biotechnology company that develops and markets products in the field of human stem cells and regenerative medicine, today announced that it has completed its acquisition of the Singapore company ES Cell International Pte Ltd.

3 May 2010

Ethicon Endo-Surgery SEDASYS CAPS system receives European Union CE Mark, Health Canada approval

Ethicon Endo-Surgery today announced that the SEDASYS® System, the first computer-assisted personalized sedation (CAPS) system, was granted a CE Mark for the European Union for routine colonoscopy and screening of the upper gastrointestinal tract (EGD procedures), and Health Canada granted regulatory approval for the SEDASYS® System for use by healthcare professional teams during routine colonoscopy.

3 May 2010

SonoSite, Physio-Control announce development collaboration for point-of-care ultrasound in EMS market

SonoSite, Inc., the world leader and specialist in hand-carried ultrasound for the point-of-care, and Physio-Control, Inc., the global leader in the development and delivery of emergency medical response solutions, today announced a market development collaboration for point-of-care ultrasound in the emergency medical services (EMS) market. This alliance will enable SonoSite to expand its presence in the pre-hospital settings with the support of Physio-Control resources and extensive sales force.

3 May 2010

Stealth interventions may help people eat better, exercise more: Study

How do you get college students to eat better? A new study from the Stanford University School of Medicine suggests that a "stealth" strategy of raising the students' awareness of environmental and social issues related to food can persuade them to eat more veggies and less ice cream.

3 May 2010

TGRD presents positive results from Phase 3 studies of azilsartan medoxomil for lowering SBP at 25th ASH

Takeda Global Research & Development Center, Inc., U.S., (TGRD U.S.) today announced results from pivotal phase 3 studies of azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB), demonstrating greater 24-hour systolic blood pressure (SBP) reduction compared to commonly prescribed ARBs olmesartan medoxomil and valsartan.

3 May 2010

Implementation of quality improvement intervention reduces medication use in premature babies: Study

A new study by Pediatrix Medical Group researchers has found that the implementation of a quality improvement intervention significantly reduces the use of a large number of medications in premature babies across a broad neonatal intensive care network.

3 May 2010

Intouch Health completes $10M private placement through Beringea-led financing round

InTouch Technologies®, Inc. (d.b.a. InTouch Health®), the world leader in Remote Presence Total Telemedicine solutions, announced today the completion of a private placement of $10 million. The financing round was led by Michigan-based Beringea through its InvestMichigan! Growth Capital Fund, which provides venture and expansion-stage capital to businesses with operations in Michigan.

3 May 2010

MEDNAX first-quarter revenue increases 10% to $332.9 million

MEDNAX, Inc. today reported non-GAAP earnings of 82 cents per share for the 2010 first quarter that was principally the result of revenue growth from acquisitions as well as operating efficiencies generated through the effective management of the Company's administrative infrastructure.

3 May 2010

Belatacept preserves kidney function in transplant recipients better than cyclosporine, says study

Two-year results from phase III clinical trials show the experimental immunosuppressive drug belatacept can better preserve kidney function in kidney transplant recipients while preventing graft rejection when compared with the standard immunosuppressive drug cyclosporine.

3 May 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Statins may improve longevity of hip replacement surgery

NIH awards Hutchinson Center $10.24M for research of breast cancer disparities in Hispanic women

Difference between grief and depression

Depressive symptoms after ACS associated with vascular brain changes

Sepracor issued FDA Complete Response Letter for STEDESA NDA

Sorin Group to distribute CardioMedical's entire Cardio Vision MIS Portfolio

Weight loss through caloric restriction and increase in physical activity improve symptoms of GERD

FDA issues advisory on prostate cancer drugs

BioTime acquires ES Cell International

Ethicon Endo-Surgery SEDASYS CAPS system receives European Union CE Mark, Health Canada approval

SonoSite, Physio-Control announce development collaboration for point-of-care ultrasound in EMS market

Stealth interventions may help people eat better, exercise more: Study

TGRD presents positive results from Phase 3 studies of azilsartan medoxomil for lowering SBP at 25th ASH

Implementation of quality improvement intervention reduces medication use in premature babies: Study

Intouch Health completes $10M private placement through Beringea-led financing round

MEDNAX first-quarter revenue increases 10% to $332.9 million

Belatacept preserves kidney function in transplant recipients better than cyclosporine, says study

Scientist to receive 2010 March of Dimes Prize in Developmental Biology

New classification of depressive subtypes of depression proposed

Investigators examine effects of family-oriented interventions on adults with chronic physical diseases

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Heart Disease News and Research

Latest Heart Disease News and Research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in